Literature DB >> 19017470

Engineering strategies to enhance nanoparticle-mediated oral delivery.

Yvonne J Yamanaka1, Kam W Leong.   

Abstract

Oral delivery is the most preferred route of drug administration due to convenience, patient compliance and cost-effectiveness. Despite these advantages it remains difficult to achieve satisfactory bioavailability levels via oral administration due to the harsh environment of the gastrointestinal (GI) tract, particularly for biomacromolecules. One promising method to increase the bioavailability of macromolecular drugs such as proteins and nucleic acids is to encapsulate them in nanoparticles before oral administration. This review describes innovative strategies for increasing the efficacy of nanoparticle-mediated delivery to the GI tract. Approaches to optimize nanoparticle formulation by exploiting mucoadhesion, environmental responsiveness and external delivery control mechanisms are discussed. The application of recent advances in nanoparticle synthesis using supercritical fluids, microfluidics and imprint lithography to oral delivery are also presented, as well as possible strategies for incorporating nanoparticles into micro- and macroscale oral delivery devices.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017470     DOI: 10.1163/156856208786440479

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  20 in total

1.  Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.

Authors:  Hamed Laroui; Arianne L Theiss; Yutao Yan; Guillaume Dalmasso; Hang T T Nguyen; Shanthi V Sitaraman; Didier Merlin
Journal:  Biomaterials       Date:  2011-02       Impact factor: 12.479

Review 2.  Expert opinion: Responsive polymer nanoparticles in cancer therapy.

Authors:  William B Liechty; Nicholas A Peppas
Journal:  Eur J Pharm Biopharm       Date:  2011-08-25       Impact factor: 5.571

Review 3.  Microscale oral delivery devices incorporating nanoparticles.

Authors:  Kyle Phua; Kam W Leong
Journal:  Nanomedicine (Lond)       Date:  2010-02       Impact factor: 5.307

Review 4.  pH-Responsive nanoparticles for drug delivery.

Authors:  Weiwei Gao; Juliana M Chan; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

5.  Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.

Authors:  Sutapa Barua; Samir Mitragotri
Journal:  Nano Today       Date:  2014-04-01       Impact factor: 20.722

6.  Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.

Authors:  D Scott Wilson; Guillaume Dalmasso; Lixin Wang; Shanthi V Sitaraman; Didier Merlin; Niren Murthy
Journal:  Nat Mater       Date:  2010-10-10       Impact factor: 43.841

7.  Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.

Authors:  Thomas F Conway; Laura Hammer; Stacia Furtado; Edith Mathiowitz; Ferdinando Nicoletti; Katia Mangano; Nejat K Egilmez; Dominick L Auci
Journal:  J Crohns Colitis       Date:  2015-05-18       Impact factor: 9.071

8.  Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit.

Authors:  Baomei Wang; Xiaoying Zhuang; Zhong-Bin Deng; Hong Jiang; Jingyao Mu; Qilong Wang; Xiaoyu Xiang; Haixun Guo; Lifeng Zhang; Gerald Dryden; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Mol Ther       Date:  2013-08-13       Impact factor: 11.454

9.  Potential biological fate of emulsion-based delivery systems: lipid particles nanolaminated with lactoferrin and β-lactoglobulin coatings.

Authors:  Tanushree Tokle; Yingyi Mao; David Julian McClements
Journal:  Pharm Res       Date:  2013-03-06       Impact factor: 4.200

10.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.